Preliminary phase 2 results of the CYPIDES study of ODM-208 in metastatic castration-resistant prostate cancer patients

被引：0
|
作者：
Cook, Natalie
Bernard-Tessier, Alice
Barthelemy, Philippe
Utriainen, Tapio
Roubaud, Guilhem
Flechon, Aude
van der Voet, Hans
Gravis Mescam, Gwenaelle
Ratta, Raffaele
Jones, Rob
Parikh, Omi
Tanner, Minna
Garratt, Chris
Nevalaita, Liina
Pohjanjousi, Pasi
Ikonen, Tarja
Antonarakis, Emmanuel
Fizazi, Karim
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs57
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [31] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [32] Evolocumab in Metastatic Castration-Resistant Prostate Cancer - study schema
    Mellor, Rhiannon
    Ardolino, Luke
    Scheinberg, Tahlia
    Sullivan, David
    Lin Hui-Ming
    Meikle, Peter
    Stockler, Martin
    Joshua, Anthony
    Horvath, Lisa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 68 - 68
  • [33] Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer
    Laber, Damian A.
    Chen, Min-Bin
    Jaglal, Michael
    Patel, Ankita
    Visweshwar, Nathan
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 473 - 481
  • [34] Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer
    Dahut, William L.
    Madan, Ravi A.
    Karakunnel, Joyson J.
    Adelberg, David
    Gulley, James L.
    Turkbey, Ismail B.
    Chau, Cindy H.
    Spencer, Shawn D.
    Mulquin, Marcia
    Wright, John
    Parnes, Howard L.
    Steinberg, Seth M.
    Choyke, Peter L.
    Figg, William D.
    BJU INTERNATIONAL, 2013, 111 (08) : 1269 - 1280
  • [35] Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
    Winquist, Eric
    Hotte, Sebastien J.
    Chi, Kim
    Sridhar, Srikala
    Ellard, Susan
    Ong, Michael
    Iqbal, Nayyer
    Salim, Muhammad
    Emmenegger, Urban
    Gingerich, Joel R.
    Lalani, Aly-Khan
    Major, Pierre
    Kollmannsberger, Christian
    Yip, Steven
    Hansen, Aaron
    Finch, Daygen
    Canil, Christina
    Hutchenreuther, James
    Vera-Badillo, Francisco
    Smoragiewicz, Martin
    Cabanero, Michael
    Tsao, Ming-Sound
    Ritch, Elie
    Wyatt, Alexander W.
    Seymour, Lesley
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 45 - 55
  • [36] A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Danila, Daniel Costin
    Waterhouse, David Michael
    Appleman, Leonard Joseph
    Pook, David William
    Matsubara, Nobuaki
    Dorff, Tanya B.
    Lee, Jae-Lyun
    Armstrong, Andrew J.
    Kim, Miso
    Horvath, Lisa
    Sumey, Christopher Joseph
    Cooner, Freda
    Salvati, Mark
    Stieglmaier, Julia
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Phase II cohort study in patients with metastatic castration-resistant prostate cancer (mCRPC) with new cohorts
    Rexer, Heidrun
    Retz, Margitta
    Hammerer, Peter
    AKTUELLE UROLOGIE, 2022, 53 (06) : 504 - 505
  • [38] Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
    Lin, Jianqing
    Elkon, Jacob
    Ricart, Brittany
    Palmer, Erica
    Zevallos-Delgado, Christian
    Noonepalle, Satish
    Burgess, Brooke
    Siegel, Robert
    Ma, Yan
    Villagra, Alejandro
    ONCOLOGIST, 2021, 26 (12): : E2136 - E2142
  • [39] A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal
    Mellado, Begona
    Shah, Satish
    Hauke, Ralph
    Costin, Dan
    Adra, Nabil
    Cullberg, Marie
    Teruel, Carlos Fernandez
    Morris, Thomas
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 278 - 285
  • [40] Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
    Petrylak, Daniel P.
    Loriot, Yohann
    Shaffer, David R.
    Braiteh, Fadi
    Powderly, John
    Harshman, Lauren C.
    Conkling, Paul
    Delord, Jean-Pierre
    Gordon, Michael
    Kim, Joseph W.
    Sarkar, Indrani
    Yuen, Kobe
    Kadel, Edward E.
    Mariathasan, Sanjeev
    O'Hear, Carol
    Narayanan, Sujata
    Fasso, Marcella
    Carroll, Susheela
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3360 - 3369
12345